Pregabalin + Methylcobalamin: Combined Therapy for Neuropathic Pain

This fixed-dose combination targets neuropathic pain through complementary mechanisms.

Mechanisms

  • Pregabalin: α₂δ ligand → binds voltage-gated Ca²⁺ channels → ↓ excitatory neurotransmitter release (glutamate, norepinephrine, substance P) → ↓ central sensitization.
  • Methylcobalamin (active B12): Coenzyme for methionine synthase → myelin synthesis, nerve regeneration, ↓ homocysteine neurotoxicity.

Indications

  • Diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia
  • Cervical/lumbar radiculopathy
  • Carpal tunnel syndrome
  • Chemotherapy-induced peripheral neuropathy (CIPN)

Advantages of Combination

  • Faster onset (pregabalin) + disease modification (methylcobalamin).
  • Lower pregabalin dose possible → fewer side effects (dizziness, edema, weight gain).
  • Improved adherence (single pill).

Dosing & Monitoring

  • Typical: Pregabalin 75 mg + Methylcobalamin 750–1500 mcg, 1–2× daily.
  • Renal adjustment for pregabalin (CrCl <60).
  • Monitor: pain scores, neurological exam, B12/folate, renal function.

Cautions

  • Pregabalin: CNS depression, misuse potential (Schedule V), angioedema, withdrawal on abrupt stop.
  • Methylcobalamin: rare allergy; high dose may mask B12 deficiency hematologically.

Use under neurologist/pain specialist guidance as part of multimodal plan.

Prescription Medications - Related Articles